Switch to:
Novo Nordisk A/S (NYSE:NVO)
EV/EBITDA
20.74 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Novo Nordisk A/S's enterprise value is $138,501 Mil. Novo Nordisk A/S's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2016 was $6,677 Mil. Therefore, Novo Nordisk A/S's EV/EBITDA ratio for today is 20.74.

NVO' s EV/EBITDA Range Over the Past 10 Years
Min: 8.2   Max: 25.1
Current: 20.16

8.2
25.1

During the past 13 years, the highest EV/EBITDA Ratio of Novo Nordisk A/S was 25.10. The lowest was 8.20. And the median was 16.40.

NVO's EV/EBITDA is ranked higher than
52% of the 276 Companies
in the Global Biotechnology industry.

( Industry Median: 20.97 vs. NVO: 20.16 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Novo Nordisk A/S's stock price is $53.54. Novo Nordisk A/S's earnings per share for the trailing twelve months (TTM) ended in Mar. 2016 was $2.00. Therefore, Novo Nordisk A/S's P/E Ratio for today is 26.73.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Novo Nordisk A/S's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=138500.920/6676.81200346
=20.74

Novo Nordisk A/S's current Enterprise Value is $138,501 Mil.
Novo Nordisk A/S's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2016 was 1941.46855251 (Jun. 2015 ) + 1899.55904706 (Sep. 2015 ) + 901.648912885 (Dec. 2015 ) + 1934.135491 (Mar. 2016 ) = $6,677 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Novo Nordisk A/S's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=53.54/2.00296407302
=26.73

Novo Nordisk A/S's share price for today is $53.54.
Novo Nordisk A/S's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2016 was 0.486006620524 (Jun. 2015 ) + 0.490616581636 (Sep. 2015 ) + 0.472493798336 (Dec. 2015 ) + 0.553847072523 (Mar. 2016 ) = $2.00.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Novo Nordisk A/S Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2ebitda 14.7618.6312.6410.6313.5717.8015.0315.9917.9621.94

Novo Nordisk A/S Quarterly Data

Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16
ev2ebitda 15.9919.8419.6020.1017.9622.3220.1518.7621.9420.49
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK